Sensitivity to Anti-tuberculosis Drugs in HIV-positive and -negative Patients in Addis Ababa
- 1 January 2001
- journal article
- Published by Taylor & Francis in Scandinavian Journal of Infectious Diseases
- Vol. 33 (12) , 914-919
- https://doi.org/10.1080/00365540110076822
Abstract
A cross-sectional survey was conducted between 1 August and 31 December, 1998 in Addis Ababa, Ethiopia to determine the rate of primary drug resistance to anti-tuberculosis drugs and to investigate its possible association with HIV infection. Sputum culture, sensitivity to first-line anti-tuberculosis drugs and HIV testing were done for 236 sputum smear-positive pulmonary tuberculosis patients. Primary drug resistance level (single or multidrug resistance) had not changed significantly since 1994. Primary resistance occurred more often among HIV-positive than among HIV-negative patients. The association between drug resistance and HIV will have a serious impact in the control of tuberculosis because in recent years the prevalence of HIV has increased dramatically in Ethiopia. Therefore, further studies on drug resistance and HIV infection and the establishment of drug resistance surveillance are recommended.Keywords
This publication has 6 references indexed in Scilit:
- The impact of human immunodeficiency virus infection on drug-resistant tuberculosis.American Journal of Respiratory and Critical Care Medicine, 1996
- The changing epidemiology of acquired drug-resistant tuberculosis in San Francisco, USAThe Lancet, 1996
- Relationship of isoniazid resistance to human immunodeficiency virus infection in patients with tuberculosis.American Journal of Respiratory and Critical Care Medicine, 1996
- Predictors and Outcome of Multidrug-Resistant TuberculosisClinical Infectious Diseases, 1995
- Surveillance of resistance to antituberculosis drugs in developing countriesTubercle and Lung Disease, 1994
- Drug susceptibility in Mycobacterium tuberculosis of a sample of patients in Guinea BissauTubercle and Lung Disease, 1993